Impact of Modifications to the Rendering of the Antibiogram on the Prescriptions of Meropenem in Pseudomonas Bacteremia

计划入组 500 人 · 首次发布于 2023 年 11 月 2 日

Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis

计划入组 29 人 · 首次发布于 2020 年 10 月 22 日

Aztreonam for Inhalation Solution (AZLI) for the Treatment of Exacerbations of Cystic Fibrosis

计划入组 16 人 · 首次发布于 2016 年 9 月 9 日

Pseudomonas aeruginosa

anti-Pseudomonas antibody

Pseudomonas vaccine (GenVec)

Phage Therapies and Novel Molecules Show Promise in Treating Chronic Pseudomonas Aeruginosa Pulmonary Infections

AstraZeneca's Gremubamab Shows Promise in Reducing Pseudomonas Infection in Bronchiectasis Patients

FDA Grants QIDP Designation to Vast Therapeutics' ALX1 for Pseudomonas Infections in Bronchiectasis